- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06060834
Impact of a Topical Cosmetic Product on Women's Hair
Impact of a Topical Cosmetic Product Intended to Promote the Health and Beauty of Women's Hair
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hair loss is commonly experienced by both men and women, with a much greater focus placed on the thinning and loss of hair in women, particularly due to hormonal changes with aging. The loss of hair has biochemical origins and when pronounced, can be a major source of psychological distress which impacts quality of life. Grandview Research Group indicates that the hair and scalp market size is estimated at over $80 billion annually, with hair loss accounting for the majority of share.
Women, in particular, spend significant amounts of money annually on products and treatments specifically focused on hair growth including injections, transplants, and stem cells. While the above treatments are available through a healthcare provider, others are off-the-shelf botanical agents and dietary supplements-some of which have been shown to be effective.
While the anecdotal claims for such products are overwhelmingly positive, very few controlled laboratory studies have been done to investigate the impact of botanical agents on hair beauty and health. While objective outcomes are available (such as the number of hairs lost daily), most individuals focus on the subjective assessments of "beauty" and related items (e.g., shininess of hair, ability to comb and style hair).
The proposed pilot study will investigate the impact of a daily topical nutritional product applied to women's hair, specific to perceived hair quality and overall well-being. Hair loss will be measured with a scanning application ("MyHairCounts") , as well as with the 60-second hair comb test. This will be an open-label study with a sample of 15 women and will be used to generate pilot data for future, larger-scale placebo-controlled studies.
Considering the anecdotal results provided by women who have used the product, coupled with the fact that botanicals and nutritional factors are known to impact hair loss/health, the hypothesis is that women will experience positive results following use, both objectively and subjectively.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tennessee
-
Memphis, Tennessee, United States, 38152
- Center for Nutraceutical and Dietary Supplement Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female
- Age 35-70 years
- Subjects should have limp or visibly thin hair, and claim to have experienced mild to moderate hair thinning
- Willing to follow the protocol requirements as evidenced by written informed consent.
- Agree not to use any medication, including vitamins and minerals, or any cosmetic products during or before the course of this study, which are designed to impact hair health.
- Willing to download the MyHairCounts | Hair Loss Prevention | Hair Density Tracking app for use in study assessments.
- Willing to come to the lab for all follow-up visits.
- Have a regular/stable menstrual cycle if not post-menopausal (e.g., 27-32 days).
- Not lactating, pregnant or planning to become pregnant during the study
- Not have any clinically significant medical history (including alopecia), medical finding or an on-going medical or psychiatric condition which in the opinion of the Investigator could jeopardize the safety of the subject, impact validity of the study results or interfere with the completion of study according to the protocol.
- Not have baldness or significant loss of hair, to the extent that the topical product would not remain on the scalp and would run off following application, or if there is such minimal or short hair that an improvement in appearance would not be able to be evaluated.
- Use of any medication or supplement for hair loss, including finasteride, any other 5 α-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to study commencement.
- No history of allergic/sensitivity reactions to product components.
- Must be able to hang loose naturally (unsecured and without hair extensions)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Application of product
Apply intervention to wet hair on scalp and massage in for 30 seconds after shampooing (if applicable), daily.
|
Cayenne Pepper, Coconut Water, Kelp, Lemon Juice, Oxynex LM, Potassium Sorbate, Red Palm Oil, Rose Water, Saw Palmetto, vitamin C
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hair Density
Time Frame: baseline
|
Hair density as determined by "MyHairCounts" application
|
baseline
|
|
Hair Density
Time Frame: After 2 weeks of treatment
|
Hair density as determined by "MyHairCounts" application
|
After 2 weeks of treatment
|
|
Hair Density
Time Frame: after 1 month of treatment
|
Hair density as determined by "MyHairCounts" application
|
after 1 month of treatment
|
|
60 second hair count
Time Frame: baseline
|
Number of hairs lost when hair is combed for 60 seconds
|
baseline
|
|
60 second hair count
Time Frame: After 2 weeks of treatment
|
Number of hairs lost when hair is combed for 60 seconds
|
After 2 weeks of treatment
|
|
60 second hair count
Time Frame: after 1 month of treatment
|
Number of hairs lost when hair is combed for 60 seconds
|
after 1 month of treatment
|
|
Self-assessment of well-being
Time Frame: baseline
|
An adaptive visual analog scale will be used to self-assess feelings of confidence, self-consciousness, motivation, and attractiveness/beautifulness on a continuous scale from 0 (not at all) to 10 (extreme).
|
baseline
|
|
Self-assessment of well-being
Time Frame: After 2 weeks of treatment
|
An adaptive visual analog scale will be used to self-assess feelings of confidence, self-consciousness, motivation, and attractiveness/beautifulness on a continuous scale from 0 (not at all) to 10 (extreme).
|
After 2 weeks of treatment
|
|
Self-assessment of well-being
Time Frame: After 1 month treatment
|
An adaptive visual analog scale will be used to self-assess feelings of confidence, self-consciousness, motivation, and attractiveness/beautifulness on a continuous scale from 0 (not at all) to 10 (extreme).
|
After 1 month treatment
|
|
Product assessment
Time Frame: after 1 month of treatment
|
An adaptive visual analog scale will be used to self-assess feelings on the smell, ease of use, and self-reported feeling of hair quality using a continuous scale from 1 (not at all) to 10 (Very much).
|
after 1 month of treatment
|
|
Self-assessment of hair
Time Frame: baseline
|
An adaptive visual analog scale will be used to self-assess feelings on subject's hair (thickness, fullness, shininess, texture, strength, appearance, satisfaction using a continuous scale from 1 (extremely poor) to 10 (Excellent) as well as compliments, split ends on a scale from 1 (Never) to 10 (Very often), ease of styling 1 (very difficult) to 10 (very easy), and speed of hair growth 1 (slow) to 10 (very fast).
|
baseline
|
|
Self-assessment of hair
Time Frame: After 2 weeks of treatment
|
An adaptive visual analog scale will be used to self-assess feelings on subject's hair (thickness, fullness, shininess, texture, strength, appearance, satisfaction using a continuous scale from 1 (extremely poor) to 10 (Excellent) as well as compliments, split ends on a scale from 1 (Never) to 10 (Very often), ease of styling 1 (very difficult) to 10 (very easy), and speed of hair growth 1 (slow) to 10 (very fast).
|
After 2 weeks of treatment
|
|
Self-assessment of hair
Time Frame: After 1 month of treatment
|
An adaptive visual analog scale will be used to self-assess feelings on subject's hair (thickness, fullness, shininess, texture, strength, appearance, satisfaction using a continuous scale from 1 (extremely poor) to 10 (Excellent) as well as compliments, split ends on a scale from 1 (Never) to 10 (Very often), ease of styling 1 (very difficult) to 10 (very easy), and speed of hair growth 1 (slow) to 10 (very fast).
|
After 1 month of treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Systolic Blood pressure
Time Frame: baseline
|
measured using an automated machine in millimeters of mercury
|
baseline
|
|
Diastolic Blood pressure
Time Frame: baseline
|
measured using an automated machine in millimeters of mercury
|
baseline
|
|
Diastolic Blood pressure
Time Frame: After 2 weeks of treatment
|
measured using an automated machine in millimeters of mercury
|
After 2 weeks of treatment
|
|
Systolic Blood pressure
Time Frame: After 2 weeks of treatment
|
measured using an automated machine in millimeters of mercury
|
After 2 weeks of treatment
|
|
Diastolic Blood pressure
Time Frame: After 1 month of treatment
|
measured using an automated machine in millimeters of mercury
|
After 1 month of treatment
|
|
Systolic Blood pressure
Time Frame: After 1 month of treatment
|
measured using an automated machine in millimeters of mercury
|
After 1 month of treatment
|
|
Heart Rate
Time Frame: baseline
|
measured using an automated machine in beats per minute
|
baseline
|
|
Heart Rate
Time Frame: After 2 weeks of treatment
|
measured using an automated machine in beats per minute
|
After 2 weeks of treatment
|
|
Heart Rate
Time Frame: After 1 month of treatment
|
measured using an automated machine in beats per minute
|
After 1 month of treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Richard Bloomer, PhD, University of Memphis
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO-FY2024-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hair Loss
-
Bionos Biotech S.L.Active, not recruitingFemale Pattern Hair Loss | Hair Loss | Hair CareSpain
-
University of British ColumbiaCompletedFemale Pattern Hair LossCanada
-
China Medical University HospitalCompleted
-
Ain Shams UniversityCompletedFemale Pattern Hair LossEgypt
-
HistogenCompleted
-
Sohag UniversityCompleted
-
Applied Biology, Inc.CompletedAlopecia | Female Pattern Hair LossUnited States, Australia, India, Italy
-
Olistic Research Labs S.L.RecruitingEarly Female Pattern Hair Loss (FPHL)Germany
-
Olistic Research Labs S.L.CompletedEarly Female Pattern Hair Loss (FPHL)Spain
-
Merz Therapeutics GmbHCompletedDiffuse Hair Loss in FemalesGermany
Clinical Trials on Topical Botanical Agent
-
Erasmus Medical CenterRecruitingSolid Tumor, AdultNetherlands
-
DEBx Medical B.V.Not yet recruitingDiabetic Foot Wounds | Diabetic Foot Ulcer (DFU) | Diabetic Foot Ulcer Treatment
-
Istanbul University - CerrahpasaCompletedOsteo Arthritis KneeTurkey (Türkiye)
-
Universita di VeronaCompletedPeri-implant MucositisItaly
-
Thrombotargets Europe S.LCompletedBurns | Traumatic LesionsSpain
-
Shiraz University of Medical SciencesCompletedDiabetic NeuropathiesIran, Islamic Republic of
-
Inonu UniversityKahramanmaras Sutcu Imam UniversityCompletedPruritus | Hemodialysis PatientsTurkey (Türkiye)
-
Northwestern UniversityWithdrawn
-
RAK Medical and Health Sciences UniversityEnrolling by invitationDisability PhysicalUnited Arab Emirates
-
University of YalovaKaramanoğlu Mehmetbey UniversityCompletedPatient Satisfaction | Vein; Spasm | Nurse Scope, PracticeTurkey